Raymond James & Associates’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$902K Sell
22,524
-1,049
-4% -$42K ﹤0.01% 2746
2024
Q2
$1.12M Sell
23,573
-88,981
-79% -$4.24M ﹤0.01% 2534
2024
Q1
$4.88M Sell
112,554
-71,122
-39% -$3.08M ﹤0.01% 1598
2023
Q4
$9.29M Sell
183,676
-10,953
-6% -$554K 0.01% 1148
2023
Q3
$8.83M Buy
194,629
+2,745
+1% +$125K 0.01% 1108
2023
Q2
$7.87M Sell
191,884
-9,070
-5% -$372K 0.01% 1202
2023
Q1
$7.18M Sell
200,954
-24,516
-11% -$876K 0.01% 1229
2022
Q4
$8.52M Sell
225,470
-12,698
-5% -$480K 0.01% 1079
2022
Q3
$10.5M Sell
238,168
-8,281
-3% -$366K 0.01% 934
2022
Q2
$9.12M Sell
246,449
-10,277
-4% -$380K 0.01% 1031
2022
Q1
$9.51M Sell
256,726
-1,259
-0.5% -$46.6K 0.01% 1099
2021
Q4
$7.85M Sell
257,985
-43,464
-14% -$1.32M 0.01% 1245
2021
Q3
$10.1M Buy
301,449
+7,511
+3% +$252K 0.01% 1051
2021
Q2
$11.7M Sell
293,938
-8,137
-3% -$325K 0.01% 988
2021
Q1
$13.6M Sell
302,075
-4,559
-1% -$205K 0.01% 860
2020
Q4
$17.3M Sell
306,634
-55,795
-15% -$3.15M 0.02% 681
2020
Q3
$17.2M Buy
362,429
+9,055
+3% +$430K 0.02% 605
2020
Q2
$20.8M Sell
353,374
-1,130
-0.3% -$66.6K 0.03% 502
2020
Q1
$16.8M Sell
354,504
-348,470
-50% -$16.5M 0.03% 519
2019
Q4
$42.5M Sell
702,974
-29,830
-4% -$1.8M 0.05% 307
2019
Q3
$43.9M Sell
732,804
-36,156
-5% -$2.17M 0.06% 282
2019
Q2
$49.4M Sell
768,960
-26,357
-3% -$1.69M 0.07% 258
2019
Q1
$64.6M Buy
795,317
+11,558
+1% +$938K 0.1% 199
2018
Q4
$42.4M Sell
783,759
-28,609
-4% -$1.55M 0.07% 243
2018
Q3
$41.9M Sell
812,368
-24
-0% -$1.24K 0.06% 275
2018
Q2
$33.9M Buy
812,392
+24,624
+3% +$1.03M 0.06% 319
2018
Q1
$34.7M Buy
787,768
+10,319
+1% +$455K 0.06% 294
2017
Q4
$39.1M Buy
777,449
+500
+0.1% +$25.2K 0.07% 255
2017
Q3
$39.4M Buy
776,949
+10,937
+1% +$555K 0.08% 231
2017
Q2
$39M Buy
766,012
+31,322
+4% +$1.59M 0.08% 232
2017
Q1
$29.5M Buy
734,690
+36,128
+5% +$1.45M 0.07% 280
2016
Q4
$33.4M Buy
698,562
+172,383
+33% +$8.25M 0.09% 230
2016
Q3
$19.3M Sell
526,179
-6
-0% -$220 0.05% 354
2016
Q2
$12.3M Buy
526,185
+12,802
+2% +$298K 0.04% 474
2016
Q1
$20.8M Buy
513,383
+15,409
+3% +$624K 0.07% 297
2015
Q4
$30.8M Buy
497,974
+11,455
+2% +$709K 0.11% 198
2015
Q3
$19.7M Buy
486,519
+12,764
+3% +$516K 0.08% 273
2015
Q2
$27.3M Buy
473,755
+30,601
+7% +$1.76M 0.1% 213
2015
Q1
$28.2M Buy
443,154
+56,372
+15% +$3.59M 0.12% 172
2014
Q4
$23.9M Buy
386,782
+139,499
+56% +$8.61M 0.12% 183
2014
Q3
$9.6M Buy
247,283
+20,616
+9% +$801K 0.06% 370
2014
Q2
$7.81M Buy
226,667
+33,693
+17% +$1.16M 0.05% 441
2014
Q1
$8.34M Buy
192,974
+27,021
+16% +$1.17M 0.06% 380
2013
Q4
$6.61M Buy
165,953
+33,474
+25% +$1.33M 0.05% 423
2013
Q3
$4.97M Buy
132,479
+12,869
+11% +$483K 0.04% 473
2013
Q2
$3.21M Buy
+119,610
New +$3.21M 0.03% 588